Cargando…

Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study

PURPOSE: To fully elucidate the relationship of serum fibrinogen and the prognosis of esophageal squamous cell carcinoma. METHODS: The concentrations of serum fibrinogen were measured by the Clauss method in a total of 1331 operable esophageal squamous cell carcinoma (ESCC) patients from the past 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yan, Li, Yin, Xing, Wenqun, Qin, Jianjun, Liu, Xianben, Zhang, Ruixiang, Sun, Haibo, Chen, Xiankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793951/ https://www.ncbi.nlm.nih.gov/pubmed/31632147 http://dx.doi.org/10.2147/CMAR.S212192

Ejemplares similares

Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
por: Zheng, Yan, et al.
Publicado: (2020)

Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer
por: Zhang, Shui-Shen, et al.
Publicado: (2016)

The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer
por: Gao, Kun, et al.
Publicado: (2021)

Application of next-generation sequencing in resistance genes of neoadjuvant chemotherapy for esophageal cancer
por: Liu, Jizhao, et al.
Publicado: (2020)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Relationship between postoperative complications of esophageal cancer surgery and season: a retrospective study
por: Liu, Xianben, et al.
Publicado: (2022)

Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years
por: Zheng, Yan, et al.
Publicado: (2015)

Preemptive analgesia in the “non-tube no fasting” fast track program for resectable esophageal carcinoma
por: Liu, Xianben, et al.
Publicado: (2022)

The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022)

Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis
por: Yu, Yongkui, et al.
Publicado: (2022)

THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma
por: Cheng, Jiwei, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study
por: Zheng, Yan, et al.
Publicado: (2019)

The feasibility of a “no tube, no fasting” fast-track recovery protocol after esophagectomy for esophageal cancer patients aged 75 and over
por: Xing, Wenqun, et al.
Publicado: (2023)

Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions
por: Zhang, Ruixiang, et al.
Publicado: (2023)

Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients
por: Qiao, Yufeng, et al.
Publicado: (2021)

The risk and prognostic factors for liver metastases in esophageal cancer patients: A large‐cohort based study
por: Luo, Peng, et al.
Publicado: (2022)

Combined fibrinogen and neutrophil‐lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma
por: Kijima, Takashi, et al.
Publicado: (2017)

The T stage of esophageal cancer can be effectively predicted by muscularis propria thickness and muscularis propria + mucosa thickness under ultrasonic gastroscopy
por: Yu, Yongkui, et al.
Publicado: (2022)

Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma
por: Huang, Xiancong, et al.
Publicado: (2023)

Is it necessary for patients with potentially resectable esophageal squamous cell cancer to receive routine preoperative brain MRI/CT?
por: Wei, Xiufeng, et al.
Publicado: (2022)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma
por: Yang, Yu-Shang, et al.
Publicado: (2017)

Prognostic Significance of the Preoperative Albumin/Fibrinogen Ratio in Patients with Esophageal Squamous Cell Carcinoma after Surgical Resection
por: Zhang, Hongdian, et al.
Publicado: (2021)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

Treatment outcomes of surgery and chemotherapy for pulmonary metastases from non-lung cancers: a propensity score-matched analysis
por: Gao, Kun, et al.
Publicado: (2023)

Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy
por: Zheng, Zhiyuan, et al.
Publicado: (2021)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
por: Wang, Jijin, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence
por: Zheng, Yan, et al.
Publicado: (2023)

Feasibility of a single mediastinal drain through the abdominal wall after esophagectomy
por: Zheng, Yan, et al.
Publicado: (2018)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

Analysis of the associated factors for severe weight loss after minimally invasive McKeown esophagectomy
por: Wang, Peiyu, et al.
Publicado: (2018)

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma
por: Liang, Yao, et al.
Publicado: (2018)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer
por: Wu, Menghui, et al.
Publicado: (2019)

Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma
por: Zhang, Danhong, et al.
Publicado: (2015)

HIPK3 Promotes Growth and Metastasis of Esophageal Squamous Cell Carcinoma via Regulation of miR-599/c-MYC Axis
por: Ba, Yufeng, et al.
Publicado: (2020)

Elevated serum fibrinogen level is an independent risk factor for IgA nephropathy
por: Zhang, Ji, et al.
Publicado: (2017)

Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer
por: Ma, Chengquan, et al.
Publicado: (2016)

Observational Safety Study of Clottafact(®) Fibrinogen Concentrate: Real-World Data in Mexico
por: Colin-Bracamontes, Ignacio, et al.
Publicado: (2020)

Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression
por: Shen, Sining, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7m2hiq480hutiop13gubtl0gr